RxDoctor Payments Data

Eddie Smith, MD

Family Medicine · Carrollton, VANPI 1710958681

Payments from drug & device makers

$691in general payments, 2019–2025

Across 41 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$148
  • AstraZeneca$110
  • AbbVie$81
  • Pfizer$64
  • Lilly USA, LLC$59
  • GSK$47
  • plus $182 from 7 others

What the payments were for

  • Food & beverage$62190%
  • Education$7010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$691 in reported general payments places this provider in the 60th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$39,574
Medicare patients
107
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$68,642
MounjaroTirzepatide26$25,385
PrilosecOmeprazole Magnesium22$20,455
EliquisApixaban22$20,002
AptiomEslicarbazepine Acetate12$16,294
EntrestoSacubitril/Valsartan11$16,294
JanumetSitagliptin Phos/Metformin Hcl11$12,544
LinzessLinaclotide13$7,452
Lacosamide41$4,560
Celecoxib58$2,719
Tolterodine Tartrate ErTolterodine Tartrate14$2,635
Trazodone Hcl65$2,478
VascepaIcosapent Ethyl12$2,295
Ventolin HfaAlbuterol Sulfate30$1,757
Potassium Chloride56$1,694

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$148$68,64262 claims
Lilly USA, LLCMounjaro$59$25,38526 claims
PfizerEliquis$64$20,00222 claims
AbbVieLinzess$81$7,45213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Carrollton

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →